Olivia Zaegel‐Faucher

574 total citations
24 papers, 233 citations indexed

About

Olivia Zaegel‐Faucher is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Olivia Zaegel‐Faucher has authored 24 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 8 papers in Virology and 8 papers in Epidemiology. Recurrent topics in Olivia Zaegel‐Faucher's work include HIV/AIDS Research and Interventions (11 papers), HIV Research and Treatment (8 papers) and HIV/AIDS drug development and treatment (8 papers). Olivia Zaegel‐Faucher is often cited by papers focused on HIV/AIDS Research and Interventions (11 papers), HIV Research and Treatment (8 papers) and HIV/AIDS drug development and treatment (8 papers). Olivia Zaegel‐Faucher collaborates with scholars based in France, Slovakia and Martinique. Olivia Zaegel‐Faucher's co-authors include Isabelle Poizot‐Martin, Sylvie Brégigeon, Veronique Obry‐Roguet, Bruno Lacarelle, Caroline Solas, Carla E. Cano, Françoise Dignat‐George, Vincent Pradel, Catherine Tamalet and C. Lions and has published in prestigious journals such as Blood, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Olivia Zaegel‐Faucher

22 papers receiving 231 citations

Peers

Countries citing papers authored by Olivia Zaegel‐Faucher

Since Specialization

Citations

This map shows the geographic impact of Olivia Zaegel‐Faucher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia Zaegel‐Faucher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia Zaegel‐Faucher more than expected).

Fields of papers citing papers by Olivia Zaegel‐Faucher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia Zaegel‐Faucher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia Zaegel‐Faucher. The network helps show where Olivia Zaegel‐Faucher may publish in the future.

Co-authorship network of co-authors of Olivia Zaegel‐Faucher

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia Zaegel‐Faucher. A scholar is included among the top collaborators of Olivia Zaegel‐Faucher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia Zaegel‐Faucher. Olivia Zaegel‐Faucher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Feasibility of Cellular Therapies in HIV Infected Patients: A Monocentric Retrospective Analysis 2022 ·Blood ·(unknown), (unknown), (unknown), (unknown), Faézeh Legrand, (unknown), (unknown), Olivia Zaegel‐Faucher, Sylvie Brégigeon, Christian Chabannon, Norbert Vey, Didier Blaise, Sabine Fürst	0
2	Dramatic decline in new HIV diagnoses in persons born in France in a large nationwide HIV cohort 2021 ·Public Health ·(unknown), André Cabié, Cyrille Delpierre, P. Puglièse, Christine Jacomet, Maxime Hentzien, Claudine Duvivier, Olivia Zaegel‐Faucher, (unknown), F. Raffi, Firouzé Bani‐Sadr	3
3	Brief Report: Frailty in Aging People Living With HIV: A Matched Controlled Study 2021 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown), Laure‐Anne Gutierrez, Pascale Leclercq, Olivia Zaegel‐Faucher, Louis Bernard, Matteo Vassallo, (unknown), Anna Ozguler, Marie Zins, Laura Nailler, Jacques Reynes, Claudine Berr, Alain Makinson	5
4	Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders? 2020 ·AIDS Care ·Olivia Zaegel‐Faucher, (unknown), (unknown), (unknown), Veronique Obry‐Roguet, Isabelle Poizot‐Martin	2
5	Unsupervised PrEP in routine practice: a new challenge? 2019 ·International Journal of STD & AIDS ·(unknown), C. Lions, Olivia Zaegel‐Faucher, Catherine Tamalet, Isabelle Poizot‐Martin	1
6	Extracellular vesicles from T cells overexpress miR-146b-5p in HIV-1 infection and repress endothelial activation 2019 ·Scientific Reports ·(unknown), Aurélie S. Leroyer, Romaric Lacroix, Stéphane Robert, Dilyana Todorova, Stéphanie Simoncini, Luc Lyonnet, (unknown), Olivia Zaegel‐Faucher, Joëlle Micallef, Isabelle Poizot‐Martin, Patrice Roll, Françoise Dignat‐George	18
7	Hepatitis C virus-microelimination program and patient trajectories after hepatitis C virus cure in an outpatient HIV clinical unit 2019 ·European Journal of Gastroenterology & Hepatology ·C. Lions, (unknown), Olivia Zaegel‐Faucher, (unknown), Sylvie Brégigeon, (unknown), Caroline Solas, Catherine Tamalet, (unknown), (unknown), (unknown), (unknown), Veronique Obry‐Roguet, Patrizia Carrieri, Isabelle Poizot‐Martin	2
8	Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55–70 Study 2019 ·Clinical Infectious Diseases ·Alain Makinson, Jonathan Dubois, Sabrina Eymard‐Duvernay, Pascale Leclercq, Olivia Zaegel‐Faucher, Louis Bernard, Matteo Vassallo, (unknown), Christian Gény, Éric Thouvenot, Dominique Costagliola, Anna Ozguler, Marie Zins, Mélanie Simony, Jacques Reynes, Claudine Berr	23
9	Cancer risk in HIV-infected patients 2018 ·AIDS ·Isabelle Poizot‐Martin, (unknown), Carla E. Cano, (unknown), Olivia Zaegel‐Faucher, (unknown), Catherine Tamalet, Françoise Dignat‐George	2
10	HIV infection and care pathway: From guidelines to clinical practice 2018 ·Médecine et Maladies Infectieuses ·Isabelle Poizot‐Martin, (unknown), Olivia Zaegel‐Faucher, C. Lions, Carla E. Cano, (unknown), (unknown), (unknown), Sylvie Brégigeon	1
11	Risk factors associated with overweight and obesity in HIV-infected people 2018 ·Medicine ·Veronique Obry‐Roguet, Sylvie Brégigeon, Carla E. Cano, C. Lions, Olivia Zaegel‐Faucher, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Isabelle Poizot‐Martin	34
12	Emergence of uncommon HIV‐1 non‐B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013‐2015 period in Marseille, Southeastern France 2018 ·Journal of Medical Virology ·Catherine Tamalet, Hervé Tissot‐Dupont, Anne Motte, Christian Tourrès, Catherine Dhiver, Isabelle Ravaux, Isabelle Poizot‐Martin, T Dieng, Christelle Tomei, Sylvie Brégigeon, Olivia Zaegel‐Faucher, (unknown), Sarah Aherfi, Saadia Mokhtari, Hervé Chaudet, Amélie Menard, Philippe Brouqui, Andréas Stein, Philippe Colson	5
13	Frailty in HIV infected people 2017 ·AIDS ·Sylvie Brégigeon, Anne Galinier, Olivia Zaegel‐Faucher, Carla E. Cano, (unknown), (unknown), (unknown), (unknown), Isabelle Poizot‐Martin	15
14	Impact of Tenofovir dose Adjustment on Both Estimated Glomerular Filtration Rate and Tenofovir trough Concentration 2016 ·Antiviral Therapy ·Sylvie Brégigeon, Caroline Solas, Olivia Zaegel‐Faucher, Veronique Obry‐Roguet, Catherine Tamalet, Isabelle Poizot‐Martin	3
15	A Case of Undiagnosed HIV Infection in a 57-Year-Old Woman with Multiple Myeloma: Consequences on Chemotherapy Efficiency and Safety 2016 ·Case Reports in Oncological Medicine ·Isabelle Poizot‐Martin, Sylvie Brégigeon, Catherine Tamalet, Réda Bouabdallah, Olivia Zaegel‐Faucher, (unknown), (unknown), Carla E. Cano, Caroline Solas	1
16	Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy 2015 ·AIDS ·Olivia Zaegel‐Faucher, Sylvie Brégigeon, Carla E. Cano, Veronique Obry‐Roguet, (unknown), Catherine Tamalet, Françoise Dignat‐George, Isabelle Poizot‐Martin	16
17	Mandibular osteonecrosis and dental exfoliation after trigeminal zoster in an HIV-infected patient 2014 ·AIDS ·Nicolas Cloarec, Olivia Zaegel‐Faucher, Sylvie Brégigeon, Carla E. Cano, C. Chossegros, (unknown), Isabelle Poizot‐Martin	8
18	Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years 2013 ·Journal of Clinical Virology ·Isabelle Poizot‐Martin, Olivia Zaegel‐Faucher, Veronique Obry‐Roguet, (unknown), (unknown), Françoise Dignat‐George, Catherine Tamalet	24
19	Renal Impairment in Patients Receiving a Tenofovir-cART Regimen 2012 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Isabelle Poizot‐Martin, Caroline Solas, (unknown), Veronique Obry‐Roguet, Vincent Pradel, Sylvie Brégigeon, Olivia Zaegel‐Faucher, Bruno Lacarelle	55
20	HIV Protease Inhibitors Do Not Cause the Accumulation of Prelamin A in PBMCs from Patients Receiving First Line Therapy: The ANRS EP45 “Aging” Study 2012 ·PLoS ONE ·Sophie Perrin, Jonathan Cremer, Olivia Zaegel‐Faucher, Jacques Reynes, P. Dellamonica, Joëlle Micallef, Caroline Solas, Bruno Lacarelle, (unknown), Élise Kaspi, Andrée Robaglia‐Schlupp, (unknown), Nicolas Lévy, Isabelle Poizot‐Martin, Pierre Cau, Patrice Roll	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact